These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16719380)

  • 1. Determination of CYP2C9-catalyzed diclofenac 4'-hydroxylation by high-performance liquid chromatography.
    Crespi CL; Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():109-13. PubMed ID: 16719380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatography analysis of CYP2C8-catalyzed paclitaxel 6alpha-hydroxylation.
    Crespi CL; Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():103-7. PubMed ID: 16719379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of CYP2C9-catalyzed diclofenac 4'-hydroxylation by high-performance liquid chromatography.
    Crespi CL; Chang TK; Waxman DJ
    Methods Mol Biol; 1998; 107():129-33. PubMed ID: 14577221
    [No Abstract]   [Full Text] [Related]  

  • 4. CYP2C19-mediated (S)-mephenytoin 4'-hydroxylation assayed by high-performance liquid chromatography with radiometric detection.
    Crespi CL; Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():115-9. PubMed ID: 16719381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D6-dependent bufuralol 1'-hydroxylation assayed by reverse-phase ion-pair high-performance liquid chromatography with fluorescence detection.
    Crespi CL; Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():121-5. PubMed ID: 16719382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a high-throughput radiometric cyp2c9 inhibition assay using tritiated diclofenac.
    Di Marco A; Marcucci I; Chaudhary A; Taliani M; Laufer R
    Drug Metab Dispos; 2005 Mar; 33(3):359-64. PubMed ID: 15608129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides.
    Yan Z; Li J; Huebert N; Caldwell GW; Du Y; Zhong H
    Drug Metab Dispos; 2005 Jun; 33(6):706-13. PubMed ID: 15764717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of CYP4A11-catalyzed lauric acid 12-hydroxylation by high-performance liquid chromatography with radiometric detection.
    Crespi CL; Chang TK; Waxman DJ
    Methods Mol Biol; 2006; 320():143-7. PubMed ID: 16719385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.
    Waxman DJ; Chang TK
    Methods Mol Biol; 2006; 320():91-6. PubMed ID: 16719377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity.
    Tang C; Shou M; Rodrigues AD
    Drug Metab Dispos; 2000 May; 28(5):567-72. PubMed ID: 10772636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J; Feng WW; Lin CC; Nomeir AA
    Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner.
    Liu KH; Kim MJ; Jung WM; Kang W; Cha IJ; Shin JG
    Drug Metab Dispos; 2005 Feb; 33(2):209-13. PubMed ID: 15537834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic roles of CYP2C9 and its variants (CYP2C9*2 and CYP2C9*3) in lornoxicam 5'-hydroxylation.
    Iida I; Miyata A; Arai M; Hirota M; Akimoto M; Higuchi S; Kobayashi K; Chiba K
    Drug Metab Dispos; 2004 Jan; 32(1):7-9. PubMed ID: 14709614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes.
    Thijssen HH; Flinois JP; Beaune PH
    Drug Metab Dispos; 2000 Nov; 28(11):1284-90. PubMed ID: 11038154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
    Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
    Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid high-performance liquid chromatographic method for the separation of hydroxylated testosterone metabolites.
    Whalley PM; Bakes D; Grime K; Weaver RJ
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):281-8. PubMed ID: 11530987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide peptides from Coriolus versicolor competitively inhibit tolbutamide 4-hydroxylation in specific human CYP2C9 isoform and pooled human liver microsomes.
    Yeung JH; Or PM
    Phytomedicine; 2011 Oct; 18(13):1170-5. PubMed ID: 21757329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of recombinant cytochrome P450 2C9 activity with diclofenac by MEKC.
    Konecný J; Jurica J; Tomandl J; Glatz Z
    Electrophoresis; 2007 Apr; 28(8):1229-34. PubMed ID: 17377945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios.
    Dorado P; Berecz R; Cáceres MC; LLerena A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(2):437-42. PubMed ID: 12742136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.
    Dorado P; Berecz R; Norberto MJ; Yasar U; Dahl ML; LLerena A
    Eur J Clin Pharmacol; 2003 Jul; 59(3):221-5. PubMed ID: 12734606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.